Capital Impact Advisors’s Usana Health Sciences USNA Stock Holding History

Capital Impact Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,908	Closed	-$1.4M	–	225
2016 Q4	$1.4M	Hold	22,908	–	–	0.58%	34
2016 Q3	$1.58M	Buy	22,908 +7,600	+50%	+$501K	0.68%	19
2016 Q2	$853K	Hold	15,308	–	–	0.4%	136
2016 Q1	$929K	Buy	15,308 +1,600	+12%	+$94.2K	0.44%	100
2015 Q4	$876K	Sell	13,708 -3,800	-22%	-$246K	0.42%	90
2015 Q3	$1.17M	Hold	17,508	–	–	0.6%	44
2015 Q2	$1.2M	Hold	17,508	–	–	0.54%	50
2015 Q1	$973K	Sell	17,508 -25,238	-59%	-$1.29M	0.44%	68
2014 Q4	$2.19M	Hold	42,746	–	–	1.03%	41
2014 Q3	$1.57K	Hold	42,746	–	–	﹤0.01%	51
2014 Q2	$1.67M	Hold	42,746	–	–	1.26%	14
2014 Q1	$1.61M	Hold	42,746	–	–	1.3%	27
2013 Q4	$1.61M	Buy	+42,746	New	+$1.64M	1.3%	30

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Impact Advisors's USNA Position: Q1 2017 in Review

Capital Impact Advisors sold out of Usana Health Sciences (USNA) in Q1 2017, closing a stake of 22,908 shares — an estimated $1.4M sold.

Capital Impact Advisors first reported a position in USNA in Q4 2013 and held it in 13 quarters. The position peaked at $2.19M in Q4 2014. 155 funds tracked by Wall St. Rank hold USNA as of Q1 2017.

Capital Impact Advisors reported no remaining Usana Health Sciences position as of Q1 2017 after selling out during the quarter.
Capital Impact Advisors sold 22,908 Usana Health Sciences shares in Q1 2017, an estimated $1.4M.
Capital Impact Advisors first reported a position in Usana Health Sciences in Q4 2013 and held it in 13 quarters.
Capital Impact Advisors's Usana Health Sciences position peaked at $2.19M in Q4 2014.
155 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2017.

Based on Capital Impact Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.